Willis Johnson & Associates’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,440
Closed -$414K 189
2025
Q3
$414K Hold
16,440
0.03% 114
2025
Q2
$414K Hold
16,440
0.03% 107
2025
Q1
$413K Hold
16,440
0.03% 103
2024
Q4
$412K Hold
16,440
0.03% 99
2024
Q3
$413K Hold
16,440
0.03% 103
2024
Q2
$409K Hold
16,440
0.03% 98
2024
Q1
$408K Hold
16,440
0.04% 101
2023
Q4
$407K Hold
16,440
0.04% 93
2023
Q3
$401K Hold
16,440
0.04% 86
2023
Q2
$401K Hold
16,440
0.04% 87
2023
Q1
$403K Buy
+16,440
New +$402K 0.05% 81

Other funds holding IBDQ

Willis Johnson & Associates's IBDQ Position: Q4 2025 in Review

Willis Johnson & Associates sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q4 2025, closing a stake of 16,440 shares — an estimated $414K sold.

Willis Johnson & Associates first reported a position in IBDQ in Q1 2023 and held it in 11 quarters. The position peaked at $414K in Q3 2025. 3 funds tracked by Wall St. Rank hold IBDQ as of Q4 2025.

  • Willis Johnson & Associates reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q4 2025 after selling out during the quarter.
  • Willis Johnson & Associates sold 16,440 iShares iBonds Dec 2025 Term Corporate ETF shares in Q4 2025, an estimated $414K.
  • Willis Johnson & Associates first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q1 2023 and held it in 11 quarters.
  • Willis Johnson & Associates's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $414K in Q3 2025.
  • 3 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q4 2025.

Based on Willis Johnson & Associates's 13F filing for Q4 2025, filed 22 Jan 2026.